Illumina Accelerator Selects Genomics Startups for Third Funding Cycle
The business accelerator has invested in synthetic biology, reproductive health, skin microbiome, and nutrition startups.
Read MorePosted by Elaine Sanchez Wilson | Dec 17, 2015 | Uncategorized |
The business accelerator has invested in synthetic biology, reproductive health, skin microbiome, and nutrition startups.
Read MorePosted by Steve Halasey | Dec 11, 2015 | Flu & Respiratory Infections, Infectious Diseases, Molecular Diagnostics |
CLIA-waived test promises the accuracy of reference laboratory tests for performance at the point of care.
Read MorePosted by Steve Halasey | Dec 8, 2015 | Molecular Diagnostics |
To improve compliance with laboratory and medical practice guidelines, labs will perform molecular testing for all positive hepatitis C antibody test results.
Read MorePosted by Elaine Sanchez Wilson | Nov 24, 2015 | Research |
University of Utah chemists have discovered a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
Read MorePosted by Elaine Sanchez Wilson | Nov 17, 2015 | Quality Systems |
For the coming year, labs are expecting more regulatory challenges amid advancing technologies.
Read More